Literature DB >> 19715114

Antifungal research strategies aiming for new targets.

Glorivee Pagán-Mercado1, Marielis E Rivera-Ruiz, Frances Segarra-Román, José R Rodríguez-Medina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19715114      PMCID： PMC3731947     

Source DB:  PubMed          Journal:  P R Health Sci J        ISSN： 0738-0658            Impact factor:   0.705


× No keyword cloud information.
  58 in total

1.  The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling.

Authors:  Cristina Reinoso-Martín; Christoph Schüller; Manuela Schuetzer-Muehlbauer; Karl Kuchler
Journal:  Eukaryot Cell       Date:  2003-12

Review 2.  Progress in functional genomics approaches to antifungal drug target discovery.

Authors:  Marianne D De Backer; Patrick Van Dijck
Journal:  Trends Microbiol       Date:  2003-10       Impact factor: 17.079

3.  Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans.

Authors:  M C Cruz; L M Cavallo; J M Görlach; G Cox; J R Perfect; M E Cardenas; J Heitman
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

Review 4.  Systemic antifungal agents. Drug interactions of clinical significance.

Authors:  E Albengres; H Le Louët; J P Tillement
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

5.  Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells.

Authors:  Aimee L Edinger; Corinne M Linardic; Gary G Chiang; Craig B Thompson; Robert T Abraham
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

6.  Discovery of cercosporamide, a known antifungal natural product, as a selective Pkc1 kinase inhibitor through high-throughput screening.

Authors:  Andrea Sussman; Karen Huss; Li-Chun Chio; Steve Heidler; Margaret Shaw; Doreen Ma; Guoxin Zhu; Robert M Campbell; Tae-Sik Park; Palaniappan Kulanthaivel; John E Scott; John W Carpenter; Mark A Strege; Matthew D Belvo; James R Swartling; Anthony Fischl; Wu-Kuang Yeh; Chuan Shih; Xiang S Ye
Journal:  Eukaryot Cell       Date:  2004-08

7.  The domain organization of human topoisomerase I.

Authors:  L Stewart; G C Ireton; J J Champoux
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

8.  Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease.

Authors:  Leah E Cowen; Sheena D Singh; Julia R Köhler; Cathy Collins; Aimee K Zaas; Wiley A Schell; Hamza Aziz; Eleftherios Mylonakis; John R Perfect; Luke Whitesell; Susan Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

9.  SUMO: regulating the regulator.

Authors:  Guillaume Bossis; Frauke Melchior
Journal:  Cell Div       Date:  2006-06-29       Impact factor: 5.130

10.  Global mRNA expression analysis in myosin II deficient strains of Saccharomyces cerevisiae reveals an impairment of cell integrity functions.

Authors:  José F Rodríguez-Quiñones; Rafael A Irizarry; Nitza L Díaz-Blanco; Félix E Rivera-Molina; Diana Gómez-Garzón; José R Rodríguez-Medina
Journal:  BMC Genomics       Date:  2008-01-23       Impact factor: 3.969
View more
  2 in total

1.  Bisbibenzyls, a new type of antifungal agent, inhibit morphogenesis switch and biofilm formation through upregulation of DPP3 in Candida albicans.

Authors:  Li Zhang; Wenqiang Chang; Bin Sun; Matthias Groh; Andreas Speicher; Hongxiang Lou
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

2.  Fungistatic effect of hydroxychloroquine, lessons from a case.

Authors:  Fazlollah Keshavarzi
Journal:  Med Mycol Case Rep       Date:  2016-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.